BackgroundCheck.run
Search For

Xin S Tan12906 Valleygate Ln, Houston, TX 77072

Known as:
Xin Tan
Related to:
Yinghui Tan 66

Xin Tan Phones & Addresses

12906 Valleygate Ln, Houston, TX 77072   

Yakima, WA   

Get Report
Control this profile

Mentions for Xin S Tan

Career records & work history

Medicine Doctors

Xin Tan

Specialties:
Internal Medicine
Work:
First Riverside Medical Care
4242 Colden St APT L17, Flushing, NY 11355
718-6614800 (phone) 718-8882701 (fax)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1989
Conditions:
Acute Upper Respiratory Tract Infections, Angina Pectoris, Anxiety Phobic Disorders, Benign Prostatic Hypertrophy, Contact Dermatitis, Disorders of Lipoid Metabolism, Gastroesophageal Reflux Disease (GERD), Hypertension (HTN), Ischemic Heart Disease, Migraine Headache, Tension Headache, Acne, Acute Bronchitis, Acute Sinusitis, Anemia, Atrial Fibrillation and Atrial Flutter, Bell's Palsy, Bronchial Asthma, Calculus of the Urinary System, Cardiac Arrhythmia, Cholelethiasis or Cholecystitis, Chronic Renal Disease, Cirrhosis, Diabetes Mellitus (DM), Epilepsy, Gastrointestinal Hemorrhage, Gout, Heart Failure, Herpes Simplex, Hypothyroidism, Infectious Liver Disease, Internal Derangement of Knee Cartilage, Iron Deficiency Anemia, Irritable Bowel Syndrome (IBS), Malignant Neoplasm of Female Breast, Osteoarthritis, Otitis Media, Parkinson's Disease, Paroxysmal Supreventricular Tachycardia (PSVT), Peptic Ulcer Disease, Pneumonia, Rheumatoid Arthritis, Rotator Cuff Syndrome and Allied Disorders, Skin and Subcutaneous Infections, Tempromandibular Joint Disorders (TMJ), Transient Cerebral Ischemia, Urinary Tract Infection (UT), Vitamin D Deficiency
Languages:
Chinese, English
Description:
Dr. Tan graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1989. He works in Flushing, NY and specializes in Internal Medicine. Dr. Tan is affiliated with New York-Presbyterian Queens and The Brooklyn Hospital Center.

Xin Tan resumes & CV records

Resumes

Xin Tan Photo 26

Grad Student At Cornell University

Location:
United States
Industry:
Higher Education
Xin Tan Photo 27

Xin Tan

Location:
United States
Xin Tan Photo 28

Xin Tan

Location:
United States

Publications & IP owners

Us Patents

Oligodeoxynucleotide Intervention For Prevention And Treatment Of Sepsis

US Patent:
2005002, Jan 27, 2005
Filed:
Apr 5, 2004
Appl. No.:
10/818158
Inventors:
Yin Chen - Pearland TX, US
Xin Tan - Manvel TX, US
Assignee:
CytoGenix, Inc. - Houston TX
International Classification:
A61K048/00
C12N015/74
C12N005/08
US Classification:
514044000, 435366000, 435320100
Abstract:
A method for producing ODNs in bacterial or fungal cells in vivo for treatment of sepsis so that, when the ODNs reach and knock down their target genes, and thereby kill bacterial or fungal cells or inhibit their growth, the bacterial or fungal accumulation in the bloodstream is held constant or diminished and the sepsis syndrome is reduced or eliminated. The invention also contemplates of certain ODNs for use in treatment of sepsis.

Oligodoxynucleotide (Odn) Libraries, Their Use In Screening For Antibacterial Agents, And Catalytic Odn Sequence For Use As An Antibacterial Agent

US Patent:
2005013, Jun 23, 2005
Filed:
Dec 23, 2003
Appl. No.:
10/743956
Inventors:
Yin Chen - Pearland TX, US
Xin Tan - Manvel TX, US
Assignee:
CytoGenix, Inc. - Houston TX
International Classification:
C12Q001/00
C12Q001/68
C12N009/22
C12N015/85
US Classification:
435004000, 435455000, 435199000, 435325000
Abstract:
A selectively inducible, single-stranded DNA (ssDNA) expression library, a method for constructing a ssDNA expression library, a method for screening ssDNA using the expression library, and a method for identifying ssDNA molecules that alter expression of bacterial gene(s) related to cell growth and toxin production and secretion. The screening library is used to, among other things, identify ODNs effective in stopping bacterial growth, killing bacteria or preventing bacteria from synthesizing and secreting their toxins, and/or to discover ODNs effective in eukaryotic (e.g., mammalian) cells for targeted alteration of gene function. The library is also useful for identifying ssDNAs or ODNs that are used as therapeutic antibacterial reagents, for identifying essential bacterial genes that can serve as targets for antibiotic discovery, and for providing a method for treatment of bacterial infections.

Nucleotides For Prevention And Treatment Of Bacterial And Fungal Pathologies

US Patent:
2007002, Jan 25, 2007
Filed:
Jun 3, 2004
Appl. No.:
10/574254
Inventors:
Yin Chen - Pearland TX, US
Xin Tan - Manvel TX, US
Assignee:
CytoGenix, Inc. - Houston TX
International Classification:
C12Q 1/68
C40B 40/02
C40B 40/08
C07H 21/04
A61K 48/00
C12N 15/74
US Classification:
435006000, 435471000, 435483000, 435252300, 435254200, 536023700, 514044000
Abstract:
A selectively inducible, single-stranded DNA (ssDNA) expression library, a method for constructing a ssDNA expression library, a method for screening ssDNA using the expression library, and a method for identifying ssDNA molecules that alter expression of bacterial and fungal gene(s) related to cell growth and toxin production and secretion. The screening library is used to, among other things, identify ODNs effective in stopping cell growth, killing bacteria or fungi, or preventing bacteria and/or fungi from synthesizing and secreting their toxins, and/or to discover ODNs effective in eukaryotic (e.g., mammalian) cells for targeted alteration of gene function. The library is also useful for identifying ssDNAs or ODNs that are used as therapeutic agents for, for instance, providing a method for treatment of bacterial infections such as sepsis.

Single-Stranded Antimicrobial Oligonucleotides And Uses Thereof

US Patent:
2008020, Aug 28, 2008
Filed:
Sep 28, 2005
Appl. No.:
11/664052
Inventors:
Yin Chen - Pearland TX, US
Xin Xing Tan - Manvel TX, US
Assignee:
CytoGenix, Inc. - Houston TX
International Classification:
A61K 31/713
C07H 21/02
C12N 15/66
A61P 31/00
C07H 21/04
C12N 5/00
US Classification:
424 44, 536 231, 4353201, 435325, 536 237
Abstract:
The current invention is directed to oligonucleotide sequences isolated from a sequence designated rbl-1 [SEQ ID NO. 19] that either kill or inhibit growth, or prevent the production of endogenously expressed toxin, of microorganisms. These ssDNA sequences, identified through use of a screening method, appear to act as modulators of essential growth functions which may act at the level of triplex formation, antisense inhibition, or as aptamers that alter gene function. The sequences, referred to as minimum functional regions, or MFRs, are useful inter alia as therapeutic agents for treatment of sepsis and other pathologies caused by microorganisms such as sepsis and/or in which microorganisms are contributory agents.

Identification Of Novel Antibacteria Agents By Screening The Single-Stranded Dna Expression Library

US Patent:
2004024, Dec 9, 2004
Filed:
Jun 3, 2003
Appl. No.:
10/453410
Inventors:
Yin Chen - Pearland TX, US
Xin Tan - Manvel TX, US
Assignee:
CytoGenix, Inc. - Houston TX
International Classification:
C12Q001/68
C07H021/04
C12N015/74
C12N001/21
US Classification:
435/006000, 536/023100, 435/472000, 435/252300
Abstract:
A selectively inducible, single-stranded DNA (ssDNA) expression library, a method for constructing a ssDNA expression library, a method for screening ssDNA using the expression library, and a method for identifying ssDNA molecules that switch on or off bacterial gene(s) related to cell growth and toxin production and secretion. The screening library is used to, among other things, identify ODNs effective in stopping bacterial growth, killing bacteria or preventing bacteria from synthesizing and secreting their toxins is the focus of the present invention and/or to discover ODNs effective in eukaryotic (e.g., mammalian) cells for targeted gene down regulation. The library is also useful for identifying ssDNAs or ODNs that are used as therapeutic antibacterial reagents, for identifying essential bacterial genes that can serve as targets for antibiotic discovery, and for providing a method for treatment of bacterial infections.

Nucleotides For Prevention And Treatment Of Bacterial And Fungal Pathologies

US Patent:
2015009, Apr 2, 2015
Filed:
Oct 27, 2014
Appl. No.:
14/524744
Inventors:
- Houston TX, US
Xin Xing Tan - Manvel TX, US
Assignee:
Star Biologics, Inc. - Houston TX
International Classification:
C12N 15/113
C12N 15/74
US Classification:
506 16, 4353201, 536 245, 43525233, 4352523, 43525411
Abstract:
A selectively inducible, single-stranded DNA (ssDNA) expression library, a method for constructing a ssDNA expression library, a method for screening ssDNA using the expression library, and a method for identifying ssDNA molecules that alter expression of bacterial and fungal gene(s) related to cell growth and toxin production and secretion. The screening library is used to, among other things, identify ODNs effective in stopping cell growth, killing bacteria or fungi, or preventing bacteria and/or fungi from synthesizing and secreting their toxins, and/or to discover ODNs effective in eukaryotic (e.g., mammalian) cells for targeted alteration of gene function. The library is also useful for identifying ssDNAs or ODNs that are used as therapeutic agents for, for instance, providing a method for treatment of bacterial infections such as sepsis.

Single-Stranded Antimicrobial Oligonucleotides And Uses Thereof

US Patent:
2014037, Dec 18, 2014
Filed:
Aug 1, 2014
Appl. No.:
14/449581
Inventors:
- Houston TX, US
Xin Xing Tan - Manvel TX, US
Assignee:
Star Biologics, Inc. - Houston TX
International Classification:
C12N 15/113
US Classification:
536 245, 4353201, 4352523
Abstract:
The current invention is directed to oligonucleotide sequences isolated from a sequence designated rbl-1 [SEQ ID NO. 19] that either kill or inhibit growth, or prevent the production of endogenously expressed toxin, of microorganisms. These ssDNA sequences, identified through use of a screening method, appear to act as modulators of essential growth functions which may act at the level of triplex formation, antisense inhibition, or as aptamers that alter gene function. The sequences, referred to as minimum functional regions, or MFRs, are useful inter alia as therapeutic agents for treatment of sepsis and other pathologies caused by microorganisms such as sepsis and/or in which microorganisms are contributory agents.

Possible Relatives

Danny Tan  Dennis C Tan  Darrel F Tan  Derek D Tan  Derrick M Tan  Darryl R Tan  Diane X Tan  Xin T Nguyen  Xin Wang  Xin W Xu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.